Abstract:Background Smoking status has been established as a known irritant of the upper and lower respiratory tracts, leading to inflammation throughout the respiratory system. Tobacco smoking is one comorbidity encountered among chronic rhinosinusitis (CRS) patients. The histopathologic features of CRS and comorbid smoking status have yet to be determined by structured histopathology and may have important implications on disease management. Methods Retrospective study of structured histopathology reports analyzing sinus tissue removed during functional endoscopic sinus surgery. Histopathology variables were compared among patients with CRS who were reported as never smokers, former smokers, or current smokers. Results A total of 285 CRS patients were included: 173 never smokers, 85 former smokers, and 27 current smokers. When compared with former smokers, current smokers demonstrated increased basement membrane thickening (88.9% vs 67.1%, P <.020). Compared with never smokers, former and current smokers collectively demonstrated increased hyperplastic changes (14.3% vs 6.9%, P < .035), increased squamous metaplasia (26.8% vs 17.3%, P < .040), and trends toward increased basement membrane thickening (72.3% vs 65.3%, P < .124) and increased fibrosis (47.3% vs 40.5%, P < .154). Conclusion Smoking status may influence histopathologic tissue-level changes in CRS disease. Interestingly, former and current smokers maintained few differences in histopathology. However, former and current smokers collectively demonstrated increased chronic inflammatory changes compared with never smokers. These findings suggest that the timing of smoking exposure has limited effect on the tissue level, rather exposure overall influences inflammatory change. These findings may have important implications on medical and surgical management of CRS disease and comorbid smoking status.

Overview of Relation Between Tobacco Smoke and Sinusitis

Prevalence of paranasal sinusitis in adults and its characteristics in smokers

Effect of tobacco on periodontal disease and oral cancer

Impact of smoking on pharmacotherapy of chronic obstructive pulmonary disease

Smoking related environmental microbes affecting the pulmonary microbiome in Chinese population

The Impact of Smoking on Subgingival Microflora: From Periodontal Health to Disease

The Impact of Smoking on Subgingival Plaque and the Development of Periodontitis: A Literature Review

Effects of Smoking on the Pathogenesis of Chronic Obstructive Pulmonary Disease

When smoke meets gut: deciphering the interactions between tobacco smoking and gut microbiota in disease development

Are healthy smokers really healthy?

Smoking and microbiome in oral, airway, gut and some systemic diseases

The role of cigarette smoke-induced epigenetic alterations in inflammation

Indoor PM<sub>2.5</sub>, tobacco smoking and chronic lung diseases: A narrative review

Differences in Airway Remodeling and Emphysematous Lesions between Rats Exposed to Smoke from New-Type and Conventional Tobacco Varieties

Research progress on the impact of smoking on innate immunity

Histopathologic Influences of Comorbid Smoking Status in Chronic Rhinosinusitis

Tobacco Smoke Induces and Alters Immune Responses in the Lung Triggering Inflammation, Allergy, Asthma and Other Lung Diseases: A Mechanistic Review

[Preliminary Study on the Relationship Between Chronic Sinusitis Histomorphology and Aerosol].

A Potential Role for the Receptor for Advanced Glycation End-Products (RAGE) in the Development of Secondhand Smoke-Induced Chronic Sinusitis

Effect of Nicotine on Staphylococcus Aureus Biofilm Formation and Virulence Factors

Advances in the relationship between periodontopathogens and respiratory diseases (Review)